BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

179 related articles for article (PubMed ID: 36961666)

  • 1. Post-COVID interstitial lung disease in symptomatic patients after COVID-19 disease.
    Fesu D; Polivka L; Barczi E; Foldesi M; Horvath G; Hidvegi E; Bohacs A; Muller V
    Inflammopharmacology; 2023 Apr; 31(2):565-571. PubMed ID: 36961666
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Asymptomatic preclinical rheumatoid arthritis-associated interstitial lung disease.
    Chen J; Shi Y; Wang X; Huang H; Ascherman D
    Clin Dev Immunol; 2013; 2013():406927. PubMed ID: 23983768
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Exertional hypoxemia is more severe in fibrotic interstitial lung disease than in COPD.
    Du Plessis JP; Fernandes S; Jamal R; Camp P; Johannson K; Schaeffer M; Wilcox PG; Guenette JA; Ryerson CJ
    Respirology; 2018 Apr; 23(4):392-398. PubMed ID: 29193512
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Respiratory symptoms as initial manifestations of interstitial lung disease in clinically amyopathic juvenile dermatomyositis: a case report with literature review.
    Xia J; Jiang G; Jin T; Shen Q; Ma Y; Wang L; Qian L
    BMC Pediatr; 2021 Nov; 21(1):488. PubMed ID: 34732158
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Clinical analysis and outcome of interstitial lung disease complicated with juvenile dermatomyositis and juvenile polymyositis.
    Sato S; Uejima Y; Nanbu M; Suganuma E; Takano T; Tanaka R; Kabuki T; Oguma E; Oh-Ishi T; Kawano Y
    Mod Rheumatol; 2017 Jul; 27(4):652-656. PubMed ID: 27588444
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pulmonary Sequelae of COVID-19: Focus on Interstitial Lung Disease.
    Johnston J; Dorrian D; Linden D; Stanel SC; Rivera-Ortega P; Chaudhuri N
    Cells; 2023 Sep; 12(18):. PubMed ID: 37759460
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Visual analogue scales for interstitial lung disease: a prospective validation study.
    Yates H; Adamali HI; Maskell N; Barratt S; Sharp C
    QJM; 2018 Aug; 111(8):531-539. PubMed ID: 29788503
    [TBL] [Abstract][Full Text] [Related]  

  • 8. COVID-19, A New Possible Mimicker of Interstitial Lung Disease Related to Primary Sjögren's Syndrome.
    Laneri A; Cerri S; Della Casa G; Moretti A; Manfredi A; Sebastiani M; Clini E; Salvarani C
    Case Rep Med; 2023; 2023():9915553. PubMed ID: 38107625
    [No Abstract]   [Full Text] [Related]  

  • 9. Kerley B lines in the lung apex - a distinct CT sign for pulmonary congestion.
    Loebelenz LI; Ebner L; Obmann VC; Huber AT; Christe A
    Swiss Med Wkly; 2019 Aug; 149():w20119. PubMed ID: 31476240
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Atypical Chest Computed Tomography Finding of Predominant Interstitial Thickening in a Patient with Coronavirus Disease 2019 (COVID-19) Pneumonia.
    Lau JYC; Khoo HW; Hui TCH; Kaw GJL; Tan CH
    Am J Case Rep; 2020 Sep; 21():e926781. PubMed ID: 32952147
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cyclophosphamide for interstitial lung disease-associated acute respiratory failure: mortality, clinical response and radiological characteristics.
    van Gemert JP; van den Berk IAH; Nossent EJ; Heunks LMA; Jonkers RE; Vlaar AP; Bonta PI
    BMC Pulm Med; 2021 Jul; 21(1):249. PubMed ID: 34320981
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prognostic value of 6-min walk stress echocardiography in patients with interstitial lung disease.
    Yasui K; Yuda S; Abe K; Asanuma K; Yanagihara N; Sudo Y; Ikeda K; Muranaka A; Otsuka M; Nagahara D; Ohnishi H; Takahashi H; Miura T; Takahashi S
    J Echocardiogr; 2021 Dec; 19(4):232-242. PubMed ID: 34091856
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Persistent Post-COVID-19 Interstitial Lung Disease. An Observational Study of Corticosteroid Treatment.
    Myall KJ; Mukherjee B; Castanheira AM; Lam JL; Benedetti G; Mak SM; Preston R; Thillai M; Dewar A; Molyneaux PL; West AG
    Ann Am Thorac Soc; 2021 May; 18(5):799-806. PubMed ID: 33433263
    [No Abstract]   [Full Text] [Related]  

  • 14. Assessing the diagnostic value of a potential screening tool for detecting early interstitial lung disease at the onset of inflammatory rheumatic diseases.
    Hoffmann T; Oelzner P; Franz M; Teichgräber U; Renz D; Förster M; Böttcher J; Kroegel C; Schulze PC; Wolf G; Pfeil A
    Arthritis Res Ther; 2022 May; 24(1):107. PubMed ID: 35551650
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Predictive Features and Clinical Presentation of Interstitial Lung Disease in Inflammatory Myositis.
    Vojinovic T; Cavazzana I; Ceruti P; Fredi M; Modina D; Berlendis M; Franceschini F
    Clin Rev Allergy Immunol; 2021 Feb; 60(1):87-94. PubMed ID: 33141387
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A Delphi consensus statement for the management of post-COVID interstitial lung disease.
    Hadda V; Suri TM; Iyer H; Jain A; Mittal S; Madan K; Mohan A; Seith Bhalla A; Sindhwani G; Dutt N; Venkatnarayan K; Nath A; Dhooria S; Kumar R; Marwah V; Karmakar S; Chaudhry D; Ayub II; Dwivedi DP; Tiwari P; Koul P; Behera AK; Saxena P; Sengupta A; Mohapatra PR; Goyal A; Christopher DJ; Guleria R
    Expert Rev Respir Med; 2022 Sep; 16(9):983-995. PubMed ID: 36154545
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cyclophosphamide for connective tissue disease-associated interstitial lung disease.
    Barnes H; Holland AE; Westall GP; Goh NS; Glaspole IN
    Cochrane Database Syst Rev; 2018 Jan; 1(1):CD010908. PubMed ID: 29297205
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Characteristics of COVID-19 Pneumonia Survivors With Resting Normoxemia and Exercise-Induced Desaturation.
    Vitacca M; Paneroni M; Brunetti G; Carlucci A; Balbi B; Spanevello A; Ambrosino N
    Respir Care; 2021 Nov; 66(11):1657-1664. PubMed ID: 34429351
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Outcome of Hospitalization for COVID-19 in Patients with Interstitial Lung Disease. An International Multicenter Study.
    Drake TM; Docherty AB; Harrison EM; Quint JK; Adamali H; Agnew S; Babu S; Barber CM; Barratt S; Bendstrup E; Bianchi S; Villegas DC; Chaudhuri N; Chua F; Coker R; Chang W; Crawshaw A; Crowley LE; Dosanjh D; Fiddler CA; Forrest IA; George PM; Gibbons MA; Groom K; Haney S; Hart SP; Heiden E; Henry M; Ho LP; Hoyles RK; Hutchinson J; Hurley K; Jones M; Jones S; Kokosi M; Kreuter M; MacKay LS; Mahendran S; Margaritopoulos G; Molina-Molina M; Molyneaux PL; O'Brien A; O'Reilly K; Packham A; Parfrey H; Poletti V; Porter JC; Renzoni E; Rivera-Ortega P; Russell AM; Saini G; Spencer LG; Stella GM; Stone H; Sturney S; Thickett D; Thillai M; Wallis T; Ward K; Wells AU; West A; Wickremasinghe M; Woodhead F; Hearson G; Howard L; Baillie JK; Openshaw PJM; Semple MG; Stewart I; Jenkins RG;
    Am J Respir Crit Care Med; 2020 Dec; 202(12):1656-1665. PubMed ID: 33007173
    [No Abstract]   [Full Text] [Related]  

  • 20. Submaximal exercise testing in the assessment of interstitial lung disease secondary to systemic sclerosis: reproducibility and correlations of the 6-min walk test.
    Buch MH; Denton CP; Furst DE; Guillevin L; Rubin LJ; Wells AU; Matucci-Cerinic M; Riemekasten G; Emery P; Chadha-Boreham H; Charef P; Roux S; Black CM; Seibold JR
    Ann Rheum Dis; 2007 Feb; 66(2):169-73. PubMed ID: 16868020
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.